IVGG therapy in Kawasaki disease: Mechanism(s) of action
- 1 November 1989
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 53 (2) , S141-S146
- https://doi.org/10.1016/0090-1229(89)90079-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndromeNature, 1989
- Kawasaki SyndromeClinical Infectious Diseases, 1988
- Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.The Journal of Experimental Medicine, 1986
- Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki diseaseNature, 1986
- DOES KAWASAKI DISEASE HAVE A RETROVIRAL AETIOLOGY?The Lancet, 1986
- Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.Journal of Clinical Investigation, 1986
- Circulating immune complexes in Kawasaki syndromeThe Pediatric Infectious Disease Journal, 1985
- VARIANT STRAIN OF PROPIONIBACTERIUM ACNES: A CLUE TO THE AETIOLOGY OF KAWASAKI DISEASEThe Lancet, 1983
- Fate of coronary aneurysms in Kawasaki disease: Serial coronary angiography and long-term follow-up studyThe American Journal of Cardiology, 1982
- Immunoregulatory abnormalities in mucocutaneous lymph node syndromeClinical Immunology and Immunopathology, 1982